11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Meet our experienced #Veristat Head of Global Medical Affairs, Atalah Haun, MD, at the " Advanced Therapies Europe 2022" in London from August 31st -1 September 2022. Don´t miss the opportunity to discuss your clinical program with Veristat.
With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs - Veristat can help.
We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.
Schedule a meeting with Atalah Haun, MD by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Website: https://www.esmo.org/meetings/esmo-congress-2022/registrationhttps://informaconnect.com/bioeurope/
9th-13th September 2022 , Paris

11 min read
Jul 7, 2026 Veristat Blog
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
2 min read
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...